Argitalpenak (16) Ikertzaileren baten partaidetza izan duten argitalpenak

2019

  1. Are there enough radiation oncologists to lead the new Spanish radiotherapy?

    Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1663-1672

  2. Cardiovascular disease and survival in non-small cell lung cancer: a multicenter prospective assessment

    Clinical and Translational Oncology, Vol. 21, Núm. 9, pp. 1220-1230

  3. Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology

    Clinical and Translational Oncology, Vol. 21, Núm. 4, pp. 420-432

  4. Impact of rectum and bladder anatomy in intrafractional prostate motion during hypofractionated radiation therapy

    Clinical and Translational Oncology, Vol. 21, Núm. 5, pp. 607-614

  5. Late toxicity after single dose HDR prostate brachytherapy and EBRT for localized prostate cancer: Clinical and dosimetric predictors in a prospective cohort study

    Radiotherapy and Oncology, Vol. 135, pp. 13-18

  6. Long-term Outcomes and Patterns of Failure Following Trimodality Treatment With Bladder Preservation for Invasive Bladder Cancer

    Urology, Vol. 124, pp. 183-190

  7. Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy

    European Urology, Vol. 76, Núm. 6, pp. 732-739

  8. Oligometastatic prostate cancer: The game is afoot

    Cancer Treatment Reviews, Vol. 73, pp. 84-90

  9. Oral and maxillary metastases: Retrospective clinical analysis of 21 cases

    Revista Espanola de Cirugia Oral y Maxilofacial, Vol. 41, Núm. 3, pp. 99-108

  10. Oral and maxillary metastases: retrospective clinical analysis of 21 cases

    Revista española de cirugía oral y maxilofacial: Publicación Oficial de la Sociedad Española de Cirugía Oral y Maxilofacial, Vol. 41, Núm. 3, pp. 99-108

  11. Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT

    European Journal of Cancer Care, Vol. 28, Núm. 5

  12. Patient-Reported Outcomes–Secondary Analysis of the SCORE-2 Trial Comparing 4 Gy × 5 to 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression

    International Journal of Radiation Oncology Biology Physics, Vol. 105, Núm. 4, pp. 760-764

  13. Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer

    Clinical Lung Cancer, Vol. 20, Núm. 4, pp. 322-329

  14. Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): A prospective multicenter study

    BMC Cancer, Vol. 19, Núm. 1

  15. Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes

    Clinical and Translational Oncology, Vol. 21, Núm. 8, pp. 1044-1051

  16. The single nucleotide variant rs2868371 associates with the risk of mortality in non-small cell lung cancer patients: A multicenter prospective validation

    Radiotherapy and Oncology, Vol. 136, pp. 29-36